2023 Oct

Designated as an "Innovative SME".

2023 Mar

Completed enrollment of 120 cases in clinical trial the first laparoscopic surgical robot.

2022 Nov

Led and secured approval of the 2023 Zhejiang "JianBing" R&D Program.

2022 Sep

Relocated headquarters to Future Si-Tech City,Yuhang District,Hangzhou.

2022 Jan

Secured RMB 360 million strategic investment from Kangji Medical (09997HK).

2021

Established headquarters and production base in Hangzhou.

2018

Core team initiated industrialization of minimally invasive surgical robots in Changzhou,Jiangsu.

2017

Undertook the "13th Five-Year" Natlonal R&D Project for minimally invasive surgical robots

2025 Jun

Completed patient enrollment for thoracic surgery clinical trial.

2025 Apr

Received NMPA approval for laparoscopic surgical robot system,indicated for urology,general surgery and gynecology.

2012

Served as lead institution in the "12th Five-Year·863 Program"for minimally invasive surgical robots.

2024 Dec

Cerified as a National High-Tech Enterprise.

Signed strategic agreement for the Tonglu National Mass Production Base.

2007

Undertook the "11th Five-Year·863 Program" for minimally invasive surgical robots.

2024 Jan

Recognized as a "Zhejiang Provincial Sci-Tech SME".

2003

Formed core R&D team,commencing pioneering research on common key technologies for surgical robots.